FDA May Refuse Imports of Drugs from Canada-Based CMI Cosmetic
The Food and Drug Administration may refuse admission of imports of pharmaceuticals from Canada-based CMI Cosmetic Manufacturers, the agency said in a warning letter dated April 25. According to the letter, a recent FDA inspection found violations of current good…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
manufacturing practice requirements at the Concord, Ontario facility. The company also failed to register with FDA, but still offered its pharmaceuticals for import into the U.S., the agency said.